Bausch Health (Bausch Health) Price-to-Operating-Cash-Flow

: 3.08 (As of Today)

View and export this data going back to 1994. Start your Free Trial

As of today (2024-04-19), Bausch Health's share price is $8.69. Bausch Health's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $2.82. Hence, Bausch Health's Price-to-Operating-Cash-Flow Ratio for today is 3.08.

The historical rank and industry rank for Bausch Health's Price-to-Operating-Cash-Flow or its related term are showing as below:

BHC' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 1.22 Med: 5.59 Max: 48.3
Current: 3.18

During the past 13 years, Bausch Health's highest Price-to-Operating-Cash-Flow Ratio was 48.30. The lowest was 1.22. And the median was 5.59.

BHC's Price-to-Operating-Cash-Flow is ranked better than
95.27% of 676 companies
in the Drug Manufacturers industry
Industry Median: 17.36 vs BHC: 3.18

Bausch Health's Cash Flow from Operations per share for the three months ended in Dec. 2023 was $1.07. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $2.82.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -1.80% per year.

During the past 13 years, Bausch Health's highest 3-Year average Operating Cash Flow per Share Growth Rate was 161.20% per year. The lowest was -32.60% per year. And the median was 2.90% per year.

Bausch Health Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Bausch Health's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Array ( [0] => - [1] => - [2] => - [3] => - [4] => - [5] => 6.92 [6] => 6.59 [7] => 6.87 [8] => - [9] => 2.80 )

Bausch Health Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

6.92

6.59

6.87

2.80

Bausch Health Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Price-to-Operating-Cash-Flow																-	-	-	2.70	2.80

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Bausch Health's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bausch Health Price-to-Operating-Cash-Flow Distribution

For the Drug Manufacturers industry and Healthcare sector, Bausch Health's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Bausch Health's Price-to-Operating-Cash-Flow falls into.

Bausch Health Price-to-Operating-Cash-Flow Calculation

Bausch Health's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	8.69	/	2.822
	=	3.08

Bausch Health's Share Price of today is $8.69.
Bausch Health's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.82.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Bausch Health Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Bausch Health's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Bausch Health (Bausch Health) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bausch Health Companies Inc (NYSE:BHC) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

BVF:Germany BVF:Germany BHC:Canada

Address

2150 Saint Elzear Boulvard West, Laval, QC, CAN, H7L 4A8

Website

https://www.bauschhealth.com

Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.

Executives

Seana Carson	officer: EVP, General Counsel	400 SOMERSET CORPORATE BLVD, BRIDGEWATER NJ 08807
John S Barresi	officer: SVP, Controller & CAO	727 FIFTH AVENUE, NEW YORK NY 10022
Richard Mulligan	director	C/O ICAHN CAPITAL LP, 767 FIFTH AVENUE, SUITE 4700, NEW YORK NY 10153
Tom George Vadaketh	officer: EVP, Chief Financial Officer	1727 JOCKEYS WAY, YARDLEY PA 19067
Robert Spurr	director, officer: U.S. President-Pharma Business	C/O BAUSCH HEALTH COMPANIES INC., 400 SOMERSET CORPORATE BLVD., BRIDGEWATER NJ 08807
Joseph F Gordon	officer: Pres&Co-Head Bausch&Lomb/Int'l	C/O BLCO, 400 SOMERSET CORPORATE BLVD., BRIDGEWATER NJ 08807
Frederick Munsch	officer: SVP, Controller and CAO	C/O BLCO, 400 SOMERSET CORPORATE BLVD., BRIDGEWATER NJ 08807
Christina Ackermann	officer: EVP AND GENERAL COUNSEL	C/O BLCO, 400 SOMERSET CORPORATE BLVD., BRIDGEWATER NJ 08807
Sam Eldessouky	officer: EVP & Chief Financial Officer	C/O BLCO, 400 SOMERSET CORPORATE BLVD., BRIDGEWATER NJ 08807
Steven D Miller	director	16690 COLLINS AVENUE, PH, SUNNY ISLE BEACH FL 33160
Von Eschenbach Andrew C.	director	C/O BLCO, 400 SOMERSET CORPORATE BLVD., BRIDGEWATER NJ 08807
De Schutter Richard U	director	C/O BLCO, 400 SOMERSET CORPORATE BLVD., BRIDGEWATER NJ 08807
Brett Icahn	director	C/O ICAHN ENTERPRISES L.P., 16690 COLLINS AVE., PH, SUNNY ISLES FL 33160
William D. Humphries	officer: EVP, COMPANY GROUP CHAIRMAN	C/O STRATA SKIN SCIENCES, INC., 5 WALNUT GROVE DRIVE SUITE 140, HORSHAM PA 19044
Valueact Capital Master Fund, L.p.	director, other: See remarks	ONE LETTERMAN DRIVE, BUILDING D, 4TH FLOOR, SAN FRANCISCO CA 94129